JANET CRUZADO: Open Payments
NPI 1124505326 · MOODY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 37 payments from 16 companies in 2025. Trend: 2023 $1,691 · 2024 $1,496 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $199 |
| Novo Nordisk Inc | 5 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
| PFIZER INC. | 2 | $44 |
| Abbott Laboratories | 2 | $44 |
| SHIELD THERAPEUTICS INC | 1 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Exact Sciences Corporation | 2 | $31 |
| Amgen Inc. | 2 | $29 |
| Corium, LLC | 1 | $23 |
Products named: TRELEGY ELLIPTA, JARDIANCE, ELIQUIS, FREESTYLE LIBRE 3, Ozempic, ACCRUFER, XIFAXAN, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
